These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9626659)

  • 1. Divergent pathways regulate ligand-independent activation of ER alpha in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells.
    Patrone C; Gianazza E; Santagati S; Agrati P; Maggi A
    Mol Endocrinol; 1998 Jun; 12(6):835-41. PubMed ID: 9626659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells.
    Patrone C; Ma ZQ; Pollio G; Agrati P; Parker MG; Maggi A
    Mol Endocrinol; 1996 May; 10(5):499-507. PubMed ID: 8732681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3.
    Ma ZQ; Santagati S; Patrone C; Pollio G; Vegeto E; Maggi A
    Mol Endocrinol; 1994 Jul; 8(7):910-8. PubMed ID: 7984152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.
    Migliaccio A; Piccolo D; Castoria G; Di Domenico M; Bilancio A; Lombardi M; Gong W; Beato M; Auricchio F
    EMBO J; 1998 Apr; 17(7):2008-18. PubMed ID: 9524123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.
    Gao QG; Chen WF; Xie JX; Wong MS
    J Neurochem; 2009 Jun; 109(5):1338-47. PubMed ID: 19476546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
    Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.
    Feng W; Webb P; Nguyen P; Liu X; Li J; Karin M; Kushner PJ
    Mol Endocrinol; 2001 Jan; 15(1):32-45. PubMed ID: 11145737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha.
    Endoh H; Maruyama K; Masuhiro Y; Kobayashi Y; Goto M; Tai H; Yanagisawa J; Metzger D; Hashimoto S; Kato S
    Mol Cell Biol; 1999 Aug; 19(8):5363-72. PubMed ID: 10409727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.
    Bunone G; Briand PA; Miksicek RJ; Picard D
    EMBO J; 1996 May; 15(9):2174-83. PubMed ID: 8641283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
    Fox EM; Miller TW; Balko JM; Kuba MG; Sánchez V; Smith RA; Liu S; González-Angulo AM; Mills GB; Ye F; Shyr Y; Manning HC; Buck E; Arteaga CL
    Cancer Res; 2011 Nov; 71(21):6773-84. PubMed ID: 21908557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s).
    Coleman KM; Dutertre M; El-Gharbawy A; Rowan BG; Weigel NL; Smith CL
    J Biol Chem; 2003 Apr; 278(15):12834-45. PubMed ID: 12566449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
    Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
    J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GRIP1 and CBP Coactivator activity by Rho GDI modulates estrogen receptor transcriptional enhancement.
    Su LF; Wang Z; Garabedian MJ
    J Biol Chem; 2002 Oct; 277(40):37037-44. PubMed ID: 12138084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.
    Kato S; Endoh H; Masuhiro Y; Kitamoto T; Uchiyama S; Sasaki H; Masushige S; Gotoh Y; Nishida E; Kawashima H; Metzger D; Chambon P
    Science; 1995 Dec; 270(5241):1491-4. PubMed ID: 7491495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1.
    Tremblay A; Tremblay GB; Labrie F; Giguère V
    Mol Cell; 1999 Apr; 3(4):513-9. PubMed ID: 10230404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.